Menu
Recruiting NCT07702123

Efficacy of Physical Activity Program in Metabolic-syndrome Females With Behcet Disease

No phase Interventional Metabolic Syndrome Behcet Disease

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: treadmill walking.
Who it may be relevant to
Registry conditions: Metabolic Syndrome, Behcet Disease. Basic parameters: 40 years — 50 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

metabolci syndrom is highly prevalent in behcet disorder females. usually physical activity is recommended to solve this problem

Detailed description

metabolci syndrom-fenales with behcet disorder (n=40) were assigned to group I or group II. Group I will perform treadmill walk for 40 minutes. group II will act as waitlist. the group will contian 20 females

Interventions

  • Behavioral treadmill walking
    metabolci syndrom-females with behcet disorder assigned to group I (n=20) will perform treadmill walk for 40 minutes, thrice weekly, for 12 weeks

Primary outcome measures

  • high density lipoprotin [Time frame: it will be asessed after 12 weeks]
Secondary outcome measures (12)
  • triglycrides [Time frame: It will be assessed after 12 weeks]
  • body mass index [Time frame: It will be assessed after 12 weeks]
  • waist circumfrence [Time frame: It will be assessed after 12 weeks]
  • fasting blood glucoses [Time frame: It will be assessed after 12 weeks]
  • systolic blood presssure [Time frame: It will be assessed after 12 weeks]
  • diastolci blood pressure [Time frame: It will be assessed after 12 weeks]
  • subjective vitality scale [Time frame: It will be assessed after 12 weeks]
  • satifaction with life scale [Time frame: It will be assessed after 12 weeks]
  • ptisburg sleep quality index [Time frame: It will be assessed after 12 weeks]
  • fatigue severity scale [Time frame: It will be assessed after 12 weeks]
  • Behcet disease -related life quality questionaire [Time frame: It will be assessed after 12 weeks]
  • ruffier index [Time frame: It will be assessed after 12 weeks]

Eligibility criteria

Inclusion criteria

  • females with metabolci syndrome
  • females with behcet disorder

Exclusion criteria

  • psychatric diseases women
  • mental diseased women

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Cairo University — Giza

Identifiers

NCT: NCT07702123 · IRB000-14233-86

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗